{"id":13799,"date":"2023-12-20T15:10:41","date_gmt":"2023-12-20T15:10:41","guid":{"rendered":"https:\/\/nhcoa.org\/es\/?p=13799"},"modified":"2023-12-20T15:10:42","modified_gmt":"2023-12-20T15:10:42","slug":"learning-more-about-the-new-covid-19-treatments","status":"publish","type":"post","link":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/","title":{"rendered":"Learning more about the new COVID-19 treatments"},"content":{"rendered":"\n<figure class=\"wp-block-image aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53-1024x576.png\" alt=\"\" class=\"wp-image-13800\" style=\"width:550px\" srcset=\"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53-980x551.png 980w, https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53-480x270.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-1 wp-block-paragraph\" style=\"font-size:15px\">Recently, the US Food and Drug Administration (FDA) approved new antiviral drugs for the treatment of the COVID-19 virus. <strong>Veklury (Remdesivir) <\/strong>is an antiviral drug meant for <strong>adults and certain pediatric patients<\/strong> infected with COVID-19, and is administered <strong>intravenously (IV drip)<\/strong> both in hospitals and outpatient settings. In tandem with the introduction of <strong>Veklury<\/strong>, the FDA has also approved immune modulators, <strong>Olumiant (Baricitinib)<\/strong> and <strong>Actemra (Tocilizumab)<\/strong>, which will only be used for certain <strong>hospitalized adults with COVID-19<\/strong>, and not in outpatient settings.<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-2 wp-block-paragraph\" style=\"font-size:15px\">The antiviral oral treatment <strong>Paxlovid (Nirmatrelvir tablets and Ritonavir tablets) <\/strong>has also been approved to treat COVID-19 in adults, both to <strong>prevent the infection entirely and to treat eligible non-hospitalized patients <\/strong>who are experiencing mild to moderate symptoms.<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-3 wp-block-paragraph\" style=\"font-size:15px\">If you have been diagnosed with COVID-19 and have symptoms, contact your healthcare professional to determine if any of these treatments are right for you. R<strong>emember that prevention and early treatment can help improve patient outcomes, reduce stress on healthcare facilities and even save lives.<\/strong><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-4 wp-block-paragraph\" style=\"font-size:15px\">However, <strong>while these treatments can be necessary for eligible patients, they are not a substitute for COVID-19 vaccination<\/strong>. These biologics and therapeutic drugs are helpful, especially in treating the infection, and can aid in prevention, but individuals are <strong>still advised to receive the COVID-19 vaccine and available booster doses<\/strong>. Find available COVID-19 vaccine and booster doses near you at <a href=\"http:\/\/vaccines.gov\" target=\"_blank\" rel=\"noreferrer noopener\">vaccines.gov<\/a>.<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-5 wp-block-paragraph\" style=\"font-size:15px\">The FDA continues to work with developers, researchers, manufacturers, the National Institutes of Health (NIH), and other partners to in the development and availability of therapeutic drugs and biologics to prevent or treat COVID-19. <strong>Check if a drug is FDA-approved by searching their database of approved drugs: <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Drugs@FDA database<\/a>.<\/strong><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-6 wp-block-paragraph\" style=\"font-size:15px\">Available treatment for COVID-19 is constantly evolving into forms and products that better respond to the virus. The products listed below are not currently licensed in the U.S. because they are not as effective against the currently circulating SARS-CoV-2 variants. Suppliers with existing stocks of these products are encouraged to hold on to them. <strong>Staying knowledgeable on these possible treatments is important, should they prove more effective in the future, against new strains of COVID-19.<\/strong><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-7 wp-block-paragraph\" style=\"font-size:15px\">Treatments awaiting FDA approval include:<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-8 wp-block-paragraph\" style=\"font-size:15px\">\u2714 Evusheld<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-9 wp-block-paragraph\" style=\"font-size:15px\">\u2714 Bebtelovimab<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-10 wp-block-paragraph\" style=\"font-size:15px\">\u2714 Sotrovimab<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-11 wp-block-paragraph\" style=\"font-size:15px\">\u2714 REGEN-COV<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-12 wp-block-paragraph\" style=\"font-size:15px\">\u2714 Bamlanivimab\/etesevimab<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-13 wp-block-paragraph\" style=\"font-size:15px\">\u2714 Bamlanivimab<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-14 wp-block-paragraph\" style=\"font-size:15px\">The Administration for Strategic Preparedness and Response (ASPR) offers summaries of key information on all outpatient therapies currently licensed or approved in the United States for COVID-19. <strong>Visit the link below for the latest updates from ASPR: <a href=\"https:\/\/aspr.hhs.gov\/COVID-19-Therapeutics\/Side-by-Side-Overview\/Pages\/default.aspx\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/aspr.hhs.gov\/COVID-19-Therapeutics\/Side-by-Side-Overview\/Pages\/default.aspx<\/a>.<\/strong><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-15 wp-block-paragraph\" style=\"font-size:15px\"><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-16 wp-block-paragraph\" style=\"font-size:15px\"><strong>References: <\/strong><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-17 wp-block-paragraph\" style=\"font-size:15px\"><a href=\"https:\/\/covidvaccineproject.org\/treatments\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/covidvaccineproject.org\/treatments\/ <\/a><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-18 wp-block-paragraph\" style=\"font-size:15px\"><a href=\"https:\/\/aspr.hhs.gov\/COVID-19\/Therapeutics\/Pages\/default.aspx\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/aspr.hhs.gov\/COVID-19\/Therapeutics\/Pages\/default.aspx <\/a><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-19 wp-block-paragraph\" style=\"font-size:15px\"><a href=\"https:\/\/aspr.hhs.gov\/COVID-19-Therapeutics\/Side-by-Side-Overview\/Pages\/default.aspx\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/aspr.hhs.gov\/COVID-19-Therapeutics\/Side-by-Side-Overview\/Pages\/default.aspx<\/a><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-20 wp-block-paragraph\" style=\"font-size:15px\"><a href=\"https:\/\/www.fda.gov\/consumers\/articulos-para-el-consumidor-en-espanol\/conozca-sus-opciones-de-tratamiento-contra-el-covid19#:~:text=%C2%BFQu%C3%A9%20tratamientos%20est%C3%A1n%20disponibles%20contra,entornos%20hospitalarios%20como%20no%20hospitalarios.\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.fda.gov\/consumers\/articulos-para-el-consumidor-en-espanol\/conozca-sus-opciones-de-tratamiento-contra-el-covid19#:~:text=%C2%BFQu%C3%A9%20tratamientos%20est%C3%A1n%20disponibles%20contra,entornos%20hospitalarios%20como%20no%20hospitalarios.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Recently, the US Food and Drug Administration (FDA) approved new antiviral drugs for the treatment of the COVID-19 virus. Veklury (Remdesivir) is an antiviral drug meant for adults and certain pediatric patients infected with COVID-19, and is administered intravenously (IV drip) both in hospitals and outpatient settings. In tandem with the introduction of Veklury, the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":13800,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"yes","footnotes":""},"categories":[9],"tags":[],"class_list":["post-13799","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Learning more about the new COVID-19 treatments - NHCOA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Learning more about the new COVID-19 treatments - NHCOA\" \/>\n<meta property=\"og:description\" content=\"Recently, the US Food and Drug Administration (FDA) approved new antiviral drugs for the treatment of the COVID-19 virus. Veklury (Remdesivir) is an antiviral drug meant for adults and certain pediatric patients infected with COVID-19, and is administered intravenously (IV drip) both in hospitals and outpatient settings. In tandem with the introduction of Veklury, the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/\" \/>\n<meta property=\"og:site_name\" content=\"NHCOA\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-20T15:10:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-20T15:10:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"nhcoa_media\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"nhcoa_media\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/\"},\"author\":{\"name\":\"nhcoa_media\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#\\\/schema\\\/person\\\/af97334cbd12a949fea7291405d4a890\"},\"headline\":\"Learning more about the new COVID-19 treatments\",\"datePublished\":\"2023-12-20T15:10:41+00:00\",\"dateModified\":\"2023-12-20T15:10:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/\"},\"wordCount\":466,\"image\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Blog-header-53.png\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/\",\"url\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/\",\"name\":\"Learning more about the new COVID-19 treatments - NHCOA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Blog-header-53.png\",\"datePublished\":\"2023-12-20T15:10:41+00:00\",\"dateModified\":\"2023-12-20T15:10:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#\\\/schema\\\/person\\\/af97334cbd12a949fea7291405d4a890\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Learning more about the new COVID-19 treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/\",\"name\":\"NHCOA\",\"description\":\"Improving lives of hispanic and latino older adults.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#\\\/schema\\\/person\\\/af97334cbd12a949fea7291405d4a890\",\"name\":\"nhcoa_media\",\"url\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/author\\\/nhcoa_media\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Learning more about the new COVID-19 treatments - NHCOA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/","og_locale":"en_US","og_type":"article","og_title":"Learning more about the new COVID-19 treatments - NHCOA","og_description":"Recently, the US Food and Drug Administration (FDA) approved new antiviral drugs for the treatment of the COVID-19 virus. Veklury (Remdesivir) is an antiviral drug meant for adults and certain pediatric patients infected with COVID-19, and is administered intravenously (IV drip) both in hospitals and outpatient settings. In tandem with the introduction of Veklury, the [&hellip;]","og_url":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/","og_site_name":"NHCOA","article_published_time":"2023-12-20T15:10:41+00:00","article_modified_time":"2023-12-20T15:10:42+00:00","og_image":[{"width":1600,"height":900,"url":"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53.png","type":"image\/png"}],"author":"nhcoa_media","twitter_card":"summary_large_image","twitter_misc":{"Written by":"nhcoa_media","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/#article","isPartOf":{"@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/"},"author":{"name":"nhcoa_media","@id":"https:\/\/nhcoa.org\/es\/#\/schema\/person\/af97334cbd12a949fea7291405d4a890"},"headline":"Learning more about the new COVID-19 treatments","datePublished":"2023-12-20T15:10:41+00:00","dateModified":"2023-12-20T15:10:42+00:00","mainEntityOfPage":{"@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/"},"wordCount":466,"image":{"@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/#primaryimage"},"thumbnailUrl":"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53.png","articleSection":["Blog"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/","url":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/","name":"Learning more about the new COVID-19 treatments - NHCOA","isPartOf":{"@id":"https:\/\/nhcoa.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/#primaryimage"},"image":{"@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/#primaryimage"},"thumbnailUrl":"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53.png","datePublished":"2023-12-20T15:10:41+00:00","dateModified":"2023-12-20T15:10:42+00:00","author":{"@id":"https:\/\/nhcoa.org\/es\/#\/schema\/person\/af97334cbd12a949fea7291405d4a890"},"breadcrumb":{"@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhcoa.org\/es\/"},{"@type":"ListItem","position":2,"name":"Learning more about the new COVID-19 treatments"}]},{"@type":"WebSite","@id":"https:\/\/nhcoa.org\/es\/#website","url":"https:\/\/nhcoa.org\/es\/","name":"NHCOA","description":"Improving lives of hispanic and latino older adults.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhcoa.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/nhcoa.org\/es\/#\/schema\/person\/af97334cbd12a949fea7291405d4a890","name":"nhcoa_media","url":"https:\/\/nhcoa.org\/es\/author\/nhcoa_media\/"}]}},"_links":{"self":[{"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/posts\/13799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/comments?post=13799"}],"version-history":[{"count":1,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/posts\/13799\/revisions"}],"predecessor-version":[{"id":13803,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/posts\/13799\/revisions\/13803"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/media\/13800"}],"wp:attachment":[{"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/media?parent=13799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/categories?post=13799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/tags?post=13799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}